WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the ...

To read this article for CME/CE, click here. December 15, 2007 (San Antonio) — Anastrozole (Arimidex, AstraZeneca) offers long-term efficacy over tamoxifen (Nolvadex, AstraZeneca), and the benefits of ...

Please provide your email address to receive an email when new articles are posted on . The combination of anastrozole and fulvestrant extended median survival of women with hormone-receptor–positive ...

4th European Breast Cancer Conference - Hamburg, Germany. March 17 2004: New data presented today 1,2, indicate that preoperative (neoadjuvant) treatment with ARIMIDEX TM (anastrozole) results in ...

The effect of anastrozole on peripheral and tumour aromatase activity and oestrogen levels in postmenopausal patients with oestrogen receptor-rich breast tumours was investigated. Twenty-six patients ...

Dec. 13, 2002 — Anastrozole (Arimidex) is clearly superior to tamoxifen as adjuvant treatment for women with early-stage breast cancer, according to the results of a randomized, double-blind trial ...

SAN ANTONIO — Postmenopausal women with ductal carcinoma in situ experienced comparable rates of recurrence but different adverse events when they received tamoxifen or anastrozole, according to ...

SEATTLE, May 05, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global anastrozole tablets market is estimated to be valued at US$ 347.7 million in 2019 and is expected to exhibit ...

Anastrozole, a drug that blocks estrogen production in postmenopausal women, has been shown to be effective in reducing a woman s risk of developing breast cancer, especially if she is at an elevated ...

AstraZeneca announces first direct-to-patient program offering the brand ARIMIDEX® (anastrozole) Tablets to patients for only $40 per month Patients with a valid prescription would get the medication ...